Moss, S.; Jurkowicz, M.; Nemet, I.; Atari, N.; Kliker, L.; Abd-Elkader, B.; Gonen, T.; Martin, E.T.; Lustig, Y.; Regev-Yochay, G.;
et al. Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season. Vaccines 2023, 11, 1624.
https://doi.org/10.3390/vaccines11101624
AMA Style
Moss S, Jurkowicz M, Nemet I, Atari N, Kliker L, Abd-Elkader B, Gonen T, Martin ET, Lustig Y, Regev-Yochay G,
et al. Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season. Vaccines. 2023; 11(10):1624.
https://doi.org/10.3390/vaccines11101624
Chicago/Turabian Style
Moss, Stephen, Menucha Jurkowicz, Ital Nemet, Nofar Atari, Limor Kliker, Bayan Abd-Elkader, Tal Gonen, Emily Toth Martin, Yaniv Lustig, Gili Regev-Yochay,
and et al. 2023. "Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season" Vaccines 11, no. 10: 1624.
https://doi.org/10.3390/vaccines11101624
APA Style
Moss, S., Jurkowicz, M., Nemet, I., Atari, N., Kliker, L., Abd-Elkader, B., Gonen, T., Martin, E. T., Lustig, Y., Regev-Yochay, G., & Mandelboim, M.
(2023). Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season. Vaccines, 11(10), 1624.
https://doi.org/10.3390/vaccines11101624